Effects of zeffix (lamivudine) in treatment of chronic hepatitis B

ABSTRACT

The results of the study on 33 cases of chronic hepatitis B treated with Zeffix (100mg = 1 tablet/day, in 2 fears continously) showed that the rate of patients who have normalized level of liver enzyme (AST and ALT) accounted for 66.6%. The sero conversion rate of HBeAg and negatiity of HBV-DNA was 48.5%. 45.5% of patients were recovered and the rate of recurrent was 9%. Zeffix has not side effects (some cases of fever, nausea, vomit of slight manifestation.